---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-22-023842"
form_type: "8-K"
ticker: "KOD"
cik: "0001468748"
company_name: "Kodiak Sciences Inc."
filed_at: "2022-11-09T23:59:59+00:00"
generated_at: "2026-06-22T01:06:16.622615+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Kodiak Sciences Q3 net loss $77M; cash $537M; Ph3 trials on track for 2023 readouts

## Summary
- Net loss of $77.0M ($1.47/sh) vs $67.5M ($1.30) in Q3 2021; increase driven by stock-based compensation.
- Cash, cash equivalents and marketable securities of $537.4M; includes $2.5M unrealized loss from interest rates.
- R&D expenses $61.7M (up from $56.0M) and G&A $17.8M (up from $11.5M) both primarily due to non-cash stock comp.
- Four Phase 3 trials (GLEAM/GLIMMER DME, DAYLIGHT wet AMD, GLOW NPDR) expected to report topline data in 2023.
- KSI-501 IND filing on track for Q4 2022; Phase 1 study expected to begin early 2023.

## SEC filing metadata
- accession: 0000950170-22-023842
- form_type: 8-K
- ticker: KOD
- cik: 0001468748
- company_name: Kodiak Sciences Inc.
- filed_at: 2022-11-09T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1468748/000095017022023842/0000950170-22-023842-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1468748/000095017022023842/kod-20221109.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-22-023842
- JSON: https://secwatch.observer/filing/0000950170-22-023842.json
- Plain text: https://secwatch.observer/filing/0000950170-22-023842.txt

## Key facts
- Earnings Releases
  Kodiak Sciences Inc. reported third quarter of 2022 results: net income $77.0 million, or $1.47 per share.
  - Period: third quarter of 2022
  - Net income: $77.0 million, or $1.47 per share
  - Result: reported results
  source text: Kodiak Sciences Inc. (the “Company”) issued a press release reporting the Company’s financial results for the quarter ended September 30, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1468748/000095017022023842/0000950170-22-023842-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.